Congress mandates blind users can operate home medical devices independently
H.R. 5605 — Medical Device Nonvisual Accessibility Act of 2025 · Filed by Jan Schakowsky (D-IL) · 26 cosponsors · Introduced Sep 26, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires medical device manufacturers to make home-use devices (like blood pressure monitors and sleep apnea machines) accessible to blind and low-vision users through nonvisual interfaces—such as audio readouts or tactile controls—comparable in effectiveness to visual interfaces. The FDA will develop accessibility standards within one year, issue final rules within two years, and manufacturers will have one year after rules are published to comply, with limited waivers available only for devices where compliance would fundamentally alter the product or impose undue hardship.
Why we flagged it
The bill's core function is to mandate accessibility standards for medical devices under FDA authority, grounded in disability rights law (Rehabilitation Act). It is regulatory in nature, not appropriations or commemorative.
What the text implies
- Manufacturers may face initial compliance costs, but the bill allows a 3-year runway (1 year for rules + 1 year for implementation + 1 year buffer), reducing disruption.
- The 'undue hardship' waiver standard is high ('clear and convincing evidence') and tied to manufacturer financial resources, limiting escape routes for large firms.
The full analysis lists 5 implications of this text.
Who stands to gain
assistive technology companies (screen reader, audio interface developers); medical device manufacturers (long-term: reduced liability, broader market access to disabled consum